Creating an Intellectual Property (IP) Portfolio: Lessons from Mayo and Myriad cases
The Mayo and Myriad rulings emphasize that just isolating a natural substance or applying a law of nature to a process is not enough to secure patent protection. These decisions have significantly affected how companies approach the creation of an IP portfolio, particularly in the life sciences and biotechnology sectors. With this context in mind, building an effective IP strategy today requires careful consideration of patent eligibility and an understanding of the legal landscape shaped by these key rulings....
Continue reading